(Q36993396)

17 August 2017

1 reference

title

Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma (English)

1 reference

17 August 2017

budesonide/formoterol

1 reference

Katherine A Lyseng-Williamson

inferred from title

author

series ordinal

2

object named as

Katherine A Lyseng-Williamson

1 reference

17 August 2017

Paul L McCormack

1

1 reference

17 August 2017

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

67

1 reference

17 August 2017

16

1 reference

17 August 2017

2407-2431

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767160-00007

17 August 2017

0 references

cites work

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767160-00007

Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767160-00007

Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767160-00007

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767160-00007

The effects of regular inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics

21 January 2018

1 reference

12 December 2020

Formoterol attenuates neutrophilic airway inflammation in asthma

1 reference

12 December 2020

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

1 reference

12 December 2020

Inhaled Glucocorticosteroid and Long-Acting beta(2)-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy : A Paradigm Shift in Asthma Management

1 reference

12 December 2020

Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone

1 reference

12 December 2020

Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders

1 reference

12 December 2020

Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells

1 reference

12 December 2020

Long-term effects of budesonide or nedocromil in children with asthma.

1 reference

12 December 2020

Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control

1 reference

12 December 2020

Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial

1 reference

12 December 2020

Budesonide/formoterol: a review of its use in asthma

1 reference

12 December 2020

Long-acting beta-agonists: anti-inflammatory properties and synergy with corticosteroids in asthma

1 reference

12 December 2020

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

12 December 2020

Scientific rationale for using a single inhaler for asthma control

1 reference

12 December 2020

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma

1 reference

12 December 2020

Safety of long-acting beta-agonists--an urgent need to clear the air.

1 reference

12 December 2020

Serious adverse events and death associated with treatment using long-acting beta-agonists

1 reference

12 December 2020

The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics.

1 reference

12 December 2020

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

1 reference

12 December 2020

Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study

1 reference

12 December 2020

Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients

1 reference

12 December 2020

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

1 reference

12 December 2020

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

1 reference

12 December 2020

Formoterol: a review of its use in chronic obstructive pulmonary disease

1 reference

12 December 2020

Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide

1 reference

12 December 2020

Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma

1 reference

12 December 2020

Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease

1 reference

12 December 2020

The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge

1 reference

12 December 2020

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

1 reference

12 December 2020

Long-acting beta(2)-agonists in the management of asthma exacerbations

1 reference

12 December 2020

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

12 December 2020

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study

1 reference

12 December 2020

Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study

1 reference

12 December 2020

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

1 reference

12 December 2020

Scintigraphic comparison of budesonide deposition from two dry powder inhalers

1 reference

12 December 2020

Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy

1 reference

12 December 2020

Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler

1 reference

12 December 2020

Severe exacerbations predict excess lung function decline in asthma.

1 reference

12 December 2020

Inhaled budesonide/formoterol combination

1 reference

12 December 2020

International Primary Care Respiratory Group (IPCRG) Guidelines: management of asthma

1 reference

12 December 2020

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

1 reference

12 December 2020

Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial

1 reference

12 December 2020

10.2165/00003495-200767160-00007

Identifiers

DOI

1 reference

PubMed ID

17983258

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

17983258